183 related articles for article (PubMed ID: 22814031)
1. Effect of HLA-matching recipients to donor noninherited maternal antigens on outcomes after mismatched umbilical cord blood transplantation for hematologic malignancy.
Rocha V; Spellman S; Zhang MJ; Ruggeri A; Purtill D; Brady C; Baxter-Lowe LA; Baudoux E; Bergamaschi P; Chow R; Freed B; Koegler G; Kurtzberg J; Larghero J; Lecchi L; Nagler A; Navarrette C; Prasad V; Pouthier F; Price T; Ratanatharathorn V; van Rood JJ; Horowitz MM; Gluckman E; Eapen M;
Biol Blood Marrow Transplant; 2012 Dec; 18(12):1890-6. PubMed ID: 22814031
[TBL] [Abstract][Full Text] [Related]
2. Allele-Level HLA Matching Impacts Key Outcomes Following Umbilical Cord Blood Transplantation for Inherited Metabolic Disorders.
Mallhi KK; Smith AR; DeFor TE; Lund TC; Orchard PJ; Miller WP
Biol Blood Marrow Transplant; 2017 Jan; 23(1):119-125. PubMed ID: 27989932
[TBL] [Abstract][Full Text] [Related]
3. Reexposure of cord blood to noninherited maternal HLA antigens improves transplant outcome in hematological malignancies.
van Rood JJ; Stevens CE; Smits J; Carrier C; Carpenter C; Scaradavou A
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19952-7. PubMed ID: 19901324
[TBL] [Abstract][Full Text] [Related]
4. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis.
Barker JN; Davies SM; DeFor T; Ramsay NK; Weisdorf DJ; Wagner JE
Blood; 2001 May; 97(10):2957-61. PubMed ID: 11342417
[TBL] [Abstract][Full Text] [Related]
5. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
van Rood JJ; Loberiza FR; Zhang MJ; Oudshoorn M; Claas F; Cairo MS; Champlin RE; Gale RP; Ringdén O; Hows JM; Horowitz MH
Blood; 2002 Mar; 99(5):1572-7. PubMed ID: 11861270
[TBL] [Abstract][Full Text] [Related]
6. Multiple unit HLA-unmatched sex-mismatched umbilical cord blood transplantation for advanced hematological malignancy.
Lister J; Gryn JF; McQueen KL; Harris DT; Rossetti JM; Shadduck RK
Stem Cells Dev; 2007 Feb; 16(1):177-86. PubMed ID: 17348813
[TBL] [Abstract][Full Text] [Related]
7. Noninherited maternal antigens identify acceptable HLA mismatches: benefit to patients and cost-effectiveness for cord blood banks.
Van der Zanden HG; Van Rood JJ; Oudshoorn M; Bakker JN; Melis A; Brand A; Scaradavou A; Rubinstein P
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1791-5. PubMed ID: 25042738
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.
Rocha V; Cornish J; Sievers EL; Filipovich A; Locatelli F; Peters C; Remberger M; Michel G; Arcese W; Dallorso S; Tiedemann K; Busca A; Chan KW; Kato S; Ortega J; Vowels M; Zander A; Souillet G; Oakill A; Woolfrey A; Pay AL; Green A; Garnier F; Ionescu I; Wernet P; Sirchia G; Rubinstein P; Chevret S; Gluckman E
Blood; 2001 May; 97(10):2962-71. PubMed ID: 11342418
[TBL] [Abstract][Full Text] [Related]
9. Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipients.
Barker JN; Martin PL; Coad JE; DeFor T; Trigg ME; Kurtzberg J; Weisdorf DJ; Wagner J
Biol Blood Marrow Transplant; 2001; 7(7):395-9. PubMed ID: 11529490
[TBL] [Abstract][Full Text] [Related]
10. Umbilical cord blood contains normal frequencies of cytotoxic T-lymphocyte precursors (ctlp) and helper T-lymphocyte precursors against noninherited maternal antigens and noninherited paternal antigens.
Falkenburg JH; van Luxemburg-Heijs SA; Lim FT; Kanhai HH; Willemze R
Ann Hematol; 1996 Apr; 72(4):260-4. PubMed ID: 8624381
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unrelated cord blood transplantation and HLA-mismatched unrelated bone marrow transplantation for adults with leukemia.
Atsuta Y; Morishima Y; Suzuki R; Nagamura-Inoue T; Taniguchi S; Takahashi S; Kai S; Sakamaki H; Kouzai Y; Kobayashi N; Fukuda T; Azuma H; Takanashi M; Mori T; Tsuchida M; Kawase T; Kawa K; Kodera Y; Kato S;
Biol Blood Marrow Transplant; 2012 May; 18(5):780-7. PubMed ID: 22008851
[TBL] [Abstract][Full Text] [Related]
12. Impact of HLA in cord blood transplantation outcomes.
Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
[TBL] [Abstract][Full Text] [Related]
13. Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
Eapen M; Klein JP; Sanz GF; Spellman S; Ruggeri A; Anasetti C; Brown M; Champlin RE; Garcia-Lopez J; Hattersely G; Koegler G; Laughlin MJ; Michel G; Nabhan SK; Smith FO; Horowitz MM; Gluckman E; Rocha V; ; ;
Lancet Oncol; 2011 Dec; 12(13):1214-21. PubMed ID: 21982422
[TBL] [Abstract][Full Text] [Related]
14. The effect of NIMA matching in adult unrelated mismatched hematopoietic stem cell transplantation - a joint study of the Acute Leukemia Working Party of the EBMT and the CIBMTR.
Pingel J; Wang T; Hagenlocher Y; Hernández-Frederick CJ; Nagler A; Haagenson MD; Fleischhauer K; Hsu KC; Verneris MR; Lee SJ; Mohty M; Polge E; Spellman SR; Schmidt AH; van Rood JJ
Bone Marrow Transplant; 2019 Jun; 54(6):849-857. PubMed ID: 30279575
[TBL] [Abstract][Full Text] [Related]
15. Consideration of noninherited maternal Ags as permissible HLA mismatches in cord blood donor selection.
Powley L; Brown C; Melis A; Li Y; Parkes G; Navarrete CV
Bone Marrow Transplant; 2016 May; 51(5):675-9. PubMed ID: 26808565
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of unrelated umbilical cord blood transplantation for 25 patients with hematological diseases].
Chang HR; Cheng Z; Chen GH; Sun AN; Qiao M; Ma X; Wang Y; Chen F; Jin HY; Lu Y; Zhang JQ; Fu CC; Jin ZM; Tang XW; Han Y; Qiu HY; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):767-73. PubMed ID: 24989292
[TBL] [Abstract][Full Text] [Related]
17. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
18. Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancy.
Eapen M; Klein JP; Ruggeri A; Spellman S; Lee SJ; Anasetti C; Arcese W; Barker JN; Baxter-Lowe LA; Brown M; Fernandez-Vina MA; Freeman J; He W; Iori AP; Horowitz MM; Locatelli F; Marino S; Maiers M; Michel G; Sanz GF; Gluckman E; Rocha V;
Blood; 2014 Jan; 123(1):133-40. PubMed ID: 24141369
[TBL] [Abstract][Full Text] [Related]
19. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Majhail NS; Brunstein CG; Tomblyn M; Thomas AJ; Miller JS; Arora M; Kaufman DS; Burns LJ; Slungaard A; McGlave PB; Wagner JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):282-9. PubMed ID: 18275894
[TBL] [Abstract][Full Text] [Related]
20. Umbilical cord blood transplantation--how, when and for whom?
Cohen Y; Nagler A
Blood Rev; 2004 Sep; 18(3):167-79. PubMed ID: 15183901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
